Chief Financial Officer
Chief Financial Officer at LIGAND PHARMACEUTICALS INC, filing insider transactions between 2026-03-04 and 2026-03-11.
| SEC ↗ |
| 2026-03-04 | LGND | Sale | 3,413 | $208.80 | $713K | SEC ↗ |
| 2026-03-04 | LGND | Sale | 53 | $200.08 | $11K | SEC ↗ |
| 2026-03-04 | LGND | Sale | 668 | $203.63 | $136K | SEC ↗ |
| 2026-03-04 | LGND | Sale | 1,457 | $205.79 | $300K | SEC ↗ |
| 2026-03-04 | LGND | Sale | 698 | $201.09 | $140K | SEC ↗ |
| 2026-03-04 | LGND | Sale | 699 | $198.71 | $139K | SEC ↗ |
| 2026-03-04 | LGND | Sale | 743 | $204.74 | $152K | SEC ↗ |
| 2026-03-04 | LGND | Sale | 950 | $201.73 | $192K | SEC ↗ |
| 2026-03-04 | LGND | Sale | 697 | $202.79 | $141K | SEC ↗ |